Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Jan. 14];9(6):s717. Available from: https://skin.dermsquared.com/skin/article/view/3770